Decision-Quality Roadmap (CapEx and OpEx Clarity, Predictable Investment)

Environment: Regulated enterprise (~1,200 employees) with mixed on-prem and cloud, vendor-heavy delivery, aging infrastructure, and DR posture under scrutiny.

• Annual “buy lists” reset each cycle with weak linkage to business requirements, run cost, or delivery capacity.
• DR posture was debated repeatedly because recovery targets and evidence were unclear or inconsistent.
• Leadership lacked a credible multi-quarter view of commitments, sequencing, dependencies, and operating cost impact.

No decision-quality system existed. The environment lacked a trusted baseline (services/assets/owners), explicit requirements, and a cost and capacity model tying choices to run cost, delivery throughput, and risk. Spend decisions became opinion-driven and re-litigated each cycle.

• Asset and service inventories conflicted across tools and vendors, with unclear ownership and lifecycle state.
• DR artifacts (runbooks, test results, findings) were incomplete or not aligned to recovery tiering.
• Procurement patterns showed one-off purchases without lifecycle, deprecation plan, or support model.
• The project pipeline exceeded delivery capacity, producing chronic deferrals and surprise work.
• Audit and board preparation triggered repeated “scramble” requests for DR status and infrastructure posture.

• Built a usable baseline: top services and enabling assets, owners, lifecycle state, and vendor responsibility.
• Captured minimum business requirements for availability, recovery targets, security posture, and delivery timelines.
• Implemented a lightweight investment gate: requirements, capacity impact, run cost impact, and risk must be explicit before approval.
• Produced an executable 6–12 month roadmap plus a 3–5 year sequencing view tied to operating cost and capacity assumptions.
• Established a monthly governance cadence: roadmap review, constraint review, and a decision log with named owners.

• DR modernization executed with tiered recovery targets and repeatable test evidence (gaps tracked to closure).
• Roadmap became the budget backbone: CapEx and OpEx commitments visible, owned, and tracked.
• Vendor commitments aligned to the roadmap with explicit deliverables, timelines, support model, and escalation paths.
• Reduced surprise work by enforcing intake discipline and tying new starts to capacity and exit criteria.
• Roadmap re-forecasted quarterly using delivered vs planned work, dependency changes, and constraint updates.

• Inventory integrity: percent of in-scope services/assets with owner, lifecycle status, and support assignment (audit-able list).
• Roadmap execution: planned vs delivered items per quarter with explicit dependency and capacity notes.
• Financial predictability: forecast vs actual CapEx/OpEx variance by category (finance-defined).
• DR evidence: test completion rate, RTO/RPO achievement by tier, and unresolved findings aging.
• Risk tracking: top risks with mitigation owners, due dates, and aging.
• TCO view: modeled 3–5 year DR TCO compared pre/post changes (assumptions documented).

(Representative outcomes I’ve delivered in similar work (not attributable to a single client): replacing ad hoc buy lists with a business-driven multi-year roadmap, materially improving DR evidence quality and audit readiness, and reducing long-run DR TCO while meeting defined recovery targets.)

• Create a one-page baseline for the top 20 services: owner, key assets, vendor responsibility, lifecycle state, and run cost signal.
• Run a decision-quality gate on one pending spend item: requirements, capacity impact, run cost impact, support model, and risk.
• Produce a 90-day stop-doing list based on capacity constraints and backlog aging, and make tradeoffs explicit.
• Collect existing DR artifacts (runbooks, last test results, open findings), tier systems into 3 categories, and identify evidence gaps.
• Stand up a weekly 30-minute roadmap cadence with one rule: no new work starts without an owner and an exit criteria.